Rhythm Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€42.40
Target price
19.12.24
€50.16
Performance (%)
-12.26%
Price
15:32
€37.20
Summary
This prediction is currently active. The prediction for Rhythm Pharmaceuticals disappoints with a performance of -12.26%. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rhythm Pharmaceuticals | -12.745% | -12.745% |
iShares Core DAX® | 2.749% | 4.620% |
iShares Nasdaq 100 | 0.470% | -0.331% |
iShares Nikkei 225® | -2.930% | -5.556% |
iShares S&P 500 | 0.679% | 0.631% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $55.00 price target on the stock, up previously from $29.00.
Ratings data for RYTM provided by MarketBeat